Clinical Trials
5 trialsNCT05405387 2026-06-05
IMPACT
University of Utah
Phase 2 Recruiting
NCT04294641 2026-01-23
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02400476 2022-05-06
An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Puma Biotechnology, Inc.
Phase 2 Completed
NCT00321893 2016-01-25
Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00005880 2008-07-24
Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia
National Cancer Institute (NCI)
Phase 2 Completed